Novo Nordisk
NVO
660 hedge funds and large institutions have $9.68B invested in Novo Nordisk in 2020 Q3 according to their latest regulatory filings, with 53 funds opening new positions, 199 increasing their positions, 240 reducing their positions, and 45 closing their positions.
123% more call options, than puts
Call options by funds: $55.8M | Put options by funds: $25.1M
18% more first-time investments, than exits
New positions opened: 53 | Existing positions closed: 45
3% more capital invested
Capital invested by funds: $9.36B → $9.68B (+$327M)
0% less funds holding
Funds holding: 661 → 660 (-1)
0.45% less ownership
Funds ownership: 15.83% → 15.38% (-0.45%)
17% less repeat investments, than reductions
Existing positions increased: 199 | Existing positions reduced: 240
25% less funds holding in top 10
Funds holding in top 10: 16 → 12 (-4)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
+$14.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$13.6M |
| 3 |
Jane Street
New York
|
+$13.5M |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
+$13.3M |
| 5 |
Wells Fargo
San Francisco,
California
|
+$11.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$121M |
| 2 |
Renaissance Technologies
New York
|
-$39.2M |
| 3 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$26.2M |
| 4 |
AllianceBernstein
Nashville,
Tennessee
|
-$24.9M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$23.8M |
NVO Hedge Fund Activity: Q3 2020 in Review
660 of the 4,970 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2020, worth a combined $9.68B — up 3.5% from $9.36B a quarter earlier.
Buyers outnumbered sellers: 53 funds opened new NVO positions and 45 closed out — a net gain of 8 holders — while 199 added to existing stakes and 240 trimmed.
The largest buyer was Fisher Asset Management, adding an estimated $14.7M. The largest seller was Arrowstreet Capital, cutting an estimated $121M.
- 660 institutional investors held Novo Nordisk (NVO) as of Q3 2020, down from 661 in Q2 2020.
- Funds reported $9.68B of Novo Nordisk stock for Q3 2020, up 3.5% quarter-over-quarter.
- 53 funds opened new Novo Nordisk positions in Q3 2020 and 45 closed out, a net change of +8 holders.
- The largest Novo Nordisk buyer in Q3 2020 was Fisher Asset Management, an estimated $14.7M added.
- The largest Novo Nordisk seller in Q3 2020 was Arrowstreet Capital, an estimated $121M sold.
Based on aggregated 13F filings for Q3 2020.